Therapeutic thresholds and mechanisms for primary non-response to infliximab in inflammatory bowel disease.
Conclusion: IBD patients with primary IFX failure generally have lower IFX trough than responders during early induction phase. Pharmacokinetic failure seems common in ulcerative colits, whereas pharmacodynamic failure appears common in Crohn's disease.
PMID: 32631131 [PubMed - as supplied by publisher]
Source: Scandinavian Journal of Gastroenterology - Category: Gastroenterology Tags: Scand J Gastroenterol Source Type: research
More News: Crohn's Disease | Gastroenterology | Inflammatory Bowel Disease | PET Scan | Remicade | Ulcerative Colitis